TUESDAY, APRIL 23, 2013

 

 

8:15 - 8:45      Welcome and Workshop Overview - Dr. Daland Juberg, Workshop Chair
“Why are we here?” - EDSP Workshop Organizing Committee
Presentation

 

 

8:45 - 8:50      Introduction to Session I - Dr. Susan Borghoff, Session Chair

Presentation

8:50 - 9:30      Review of in vitro Assays - Validation Results and Methods for Improving in vitro Tier 1 Endocrine Disruption Screening Assays - – Dr. Colleen Toole, Ceetox Presentation

 

9:30 - 10:10    Review of in vivo Mammalian Assays - Challenges and Considerations for Conducting and Interpreting These Screening Assays - Dr. Leah Zorrilla, ILS, Inc.

Presentation

 

10:10- 10:45   BREAK     

 

    
10:45 - 11:30  Review of Non-mammalian Assays - Challenges and Potential Solutions for the Conduct and Interpretation of the Amphibian Metamorphosis Assay and the Fish Short Term Reproduction Assay - – Dr. Katherine Coady, The Dow Chemical Company

Presentation

 

 

11:30 - 12:15  Panel Discussion and Audience Q&A : Dr. Ronald Biever, Smithers Viscient; Dr. Donald Stump, WIL Research; Dr. Kun (Sue) Yi, Syngenta Crop Protection

 

 

12:15 - 1:15    LUNCH

 

1:15 - 1:20      Introduction to Session II - Dr. Sue Marty, Session Chair

 

1:20 - 2:00      A Two-Tiered-Testing Decision Tree for Assays in the USEPA-EDSP Screening Battery:   Using 15 years of experience to improve screening and testing for endocrine active chemicals - Dr. L. Earl Gray Jr., US Environmental Protection Agency
Presentation

 

 

2:00 - 2:40      Pulling it Together – Preparing for a Weight of Evidence Assessment on Endocrine Activity – Dr. Sue Marty, The Dow Chemical Co.
Presentation

 

 

2:40 - 3:15      BREAK

 

3:15 - 3:55      A Weight of Evidence Approach to Examine Endocrine Activity - Dr. Christopher Borgert, Applied Pharmacology & Toxicology, Inc.

Presentation

 

3:55 - 4:45      Panel Discussion and Audience Q&A: Patricia Bishop, PETA; Dr. Kevin Crofton, US EPA; Dr. Ellen Mihaich, ER2 and Endocrine Policy Forum

 

4:45 - 5:00      Day One Wrap Up and Prelude to Day Two - Dr. Daland Juberg, Workshop Chair

 

 

8:00 - 8:25      Welcome Back
Report from Poster Session, Dr. Richard Becker, American Chemistry Council

Presentation

8:25 - 8:30      Introduction to Session III - Dr. Warren Casey, NIEHS; Dr. Jack Fowle, EPA, retired; and, Dr. Richard Becker, American Chemistry Council; Session Co-Chairs

Presentation

 

8:30 - 9:00      EPA ToxCast HTS Assays and Prediction Models for Estrogen, Androgen, Thyroid and Steroidogenesis Pathways - Dr. David Dix, EPA NCCT

Presentation

 

 

9:00 - 9:30      Tier 1 and Done: Developing in vitro Cell-based Assays of Endocrine Pathways Sufficient by Themselves for 21st Century Risk Assessment – Dr. Mel Andersen, The Hamner Institutes for Health Sciences

Presentation

 

9:30 - 10:00    Mapping the Human Toxome by Systems Toxicology - Using ED as a Proof of Concept - Dr. Thomas Hartung, Center for Alternatives to Animal Testing, Johns Hopkins 

Presentation

10:00- 10:15   BREAK

 

10:15 - 10:35  The Future of Endocrine Screening: An Animal Welfare Perspective – Dr. Catherine Willett, Humane Society of the United States

Presentation

 

10:35 - 10:55  Road Map for Building Scientific Confidence in HTP Assays- Dr. David Geter, Bayer CropScience, Presented by Dr. Lisa Ortego
Presentation

 

 

10:55 - 11:15  Designing the Next Generation of Sustainable Chemicals - Thaddeus Schug, NIEHS

Presentation

 

 

11:15 - 12:00  Panel Discussion and Audience Q&A

 

 

12:00 - 12:45  LUNCH

 

12:45 - 2:30    Dr. James C. Lamb, IV, Exponent, Inc., Opening Remarks
Dr. Michael Dourson, TERA, Facilitator

 

2:30 - 2:45      Dr. Daland Juberg, Workshop Chair